Crossmark

Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer

Crossref DOI link: https://doi.org/10.1038/s41598-020-58339-2

Published Online: 2020-01-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pantano, Francesco

Rossi, Elisabetta https://orcid.org/0000-0002-5242-9568
Iuliani, Michele https://orcid.org/0000-0003-3536-7630
Facchinetti, Antonella https://orcid.org/0000-0002-5628-5899
Simonetti, Sonia

Ribelli, Giulia

Zoccoli, Alice https://orcid.org/0000-0003-1991-1667
Vincenzi, Bruno

Tonini, Giuseppe

Zamarchi, Rita

Santini, Daniele
License Information

Text and Data Mining valid from 2020-01-28

Version of Record valid from 2020-01-28
More Information

Article History

Received: 18 February 2019

Accepted: 6 January 2020

First Online: 28 January 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below